The Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas receptor axis: a potential target for treating thrombotic diseases.

Despite many therapeutic advances leading to increasingly effective drug treatments, thrombotic events (such as ischaemic stroke, pulmonary embolism, deep venous thrombosis and acute myocardial infarction) still represent a major worldwide cause of morbidity and mortality. Remarkable effort has been made to identify new drug targets. There is growing evidence indicating that the recently described counter-regulator axis of the renin-angiotensin system (RAS), composed of Angiotensin-Converting Enzyme 2 (ACE2), Angiotensin-(1-7) and the Mas receptor, has protective effects against thrombosis. In addition, it could be considered as a promising target for treating or preventing this disease. In this narrative review, we focused on the recent findings of the role of the ACE2/Angiotensin-(1-7)/Mas axis on the haemostatic process and its therapeutic potential.

Risorse UNIGE


Titolo: The Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas receptor axis: a potential target for treating thrombotic diseases.
Autori: 
MONTECUCCO, FABRIZIO
mostra contributor esterni 
Data di pubblicazione: 2012
Rivista: 
THROMBOSIS AND HAEMOSTASIS  
Handle: http://hdl.handle.net/11567/450520
Appare nelle tipologie:01.01 - Articolo su rivista

File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie
Logo CINECA  Copyright © 2021